Patents by Inventor Karel Z. Newman

Karel Z. Newman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5955582
    Abstract: Methods of preparing a boronate-antigen complex for immunization of animals, a monoclonal antibody specific for the same, an immunoassay method for detection of the complex and a method of calculating the amount of a target glycated protein within the sample useful in the diagnostic monitoring of diabetes are disclosed. An immunoassay kit based on this reagent is also disclosed.
    Type: Grant
    Filed: September 26, 1997
    Date of Patent: September 21, 1999
    Assignee: Beckman Coulter, Inc.
    Inventors: Karel Z. Newman, Bruce Odegaard, Godwin Orji Ogbonna, Jane A. Schmidt
  • Patent number: 5801064
    Abstract: Solid phase reagents having immobilized thereon novel single-chain Fv antibodies specific to SS-A/Ro autoantigens have been developed for use in immunoassays to detect the presence or amount of autoantibodies to such autoantigens in a test sample. The solid phase reagents can also be used to purify autoantigen. Diagnostic test kits which contain these single-chain Fv antibodies specific to SS-A/Ro autoantigen useful in immunoassays are also described.
    Type: Grant
    Filed: December 4, 1995
    Date of Patent: September 1, 1998
    Inventors: Mark D. Foresman, Jyotsna Ghai, Karel Z. Newman
  • Patent number: 5187080
    Abstract: Nucleic acid molecules are provided which encode antigenic proteins capable of inducing in a chicken an immune response conferring protection against Eimeria tenella. Expression vectors containing the nucleic acid molecules are also provided. Methods for producing the proteins or antigenic polypeptides having amino acid sequences included within these proteins are also provided.
    Type: Grant
    Filed: January 21, 1992
    Date of Patent: February 16, 1993
    Assignee: Solvay & Cie S.A.
    Inventors: William H. Andrews, Virginia M. Brothers, James G. Files, Irene Kuhn, Michael T. McCaman, Stacey R. Sias, Leland S. Paul, Thomas C. Gore, Karel Z. Newman, Jr., John L. Tedesco
  • Patent number: 4874705
    Abstract: A genomic DNA molecule having the nucleic acid sequence set forth in FIG. 1 and encoding an antigenic protein derived from Eimeria tenella has been isolated. The protein has a molecular weight of about 25,000 daltons and is composed of two polypeptides joined by a disulfide bond. One of the polypeptides is characterized by a molecular weight of about 17,000 daltons and by a blocked N-terminal amino acid and having the amino acid sequence set forth in FIG. 1. The other polypeptide is characterized by a molecular weight of about 8,000 daltons and has the amino acid sequence set forth in FIG. 1.A cDNA molecule encoding the 25,000 dalton polypeptide with a continuous amino acid sequence has been inserted into expression vectors capable of expressing the 25,000 dalton polypeptide directly or as a fused polypeptide. The polypeptides produced are used in vaccines to immunize chickens against infection by Eimeria tenella.
    Type: Grant
    Filed: December 6, 1985
    Date of Patent: October 17, 1989
    Assignee: Solvay & Cie, S.A.
    Inventors: William H. Andrews, Virginia M. Brothers, James G. Files, Irene Kuhn, Michael T. McCaman, Leland S. Paul, Stacey R. Sias, Thomas C. Gore, Karel Z. Newman, Jr., John L. Tedesco